PellePharm Competitors and Similar CompaniesClear all

PellePharm's competitors and similar companies include Harbour Antibodies, GrayBug and PDC Line Pharma.
PellePharm
PellePharm
PellePharm, Inc. operates in the biotechnology industry.
Harbour Antibodies
Harbour Antibodies
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
GrayBug
GrayBug
GrayBug is a biotechnology company developing technologies to treat eye diseases.
PDC Line Pharma
PDC Line Pharma
PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens.
Founding Date
Founding Date
2012
Founding Date
2006
Founding Date
2011
Founding Date
2014
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
San Francisco, US HQ
Locations
Newton, US HQ
Locations
Redwood City, US HQ
Baltimore, US
Locations
La Tronche, FR HQ
Liège, BE
Employees
Employees
5
Employees
1
Employees
4
Employees
375% decrease

Funding

Latest funding round
Latest funding round
$ 70m (over 7 years ago)
Latest funding round
$ 3.2m (almost 13 years ago)
Latest funding round
$ 80m (almost 7 years ago)
Latest funding round
$ 22.2m (over 6 years ago)
Total funding raised
Total funding raised
$ 81.4m
Total funding raised
$ 3.2m
Total funding raised
$ 128.5m
Total funding raised
$ 26.5m
For sources of this data, please see the company profile

View Company Profiles

Harbour Antibodies
HQ
Newton, US
Employees
1

Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.

View company
GrayBug
HQ
Redwood City, US
Employees
4

GrayBug is a biotechnology company developing technologies to treat eye diseases.

View company
PDC Line Pharma
HQ
La Tronche, FR
Employees
37↓ 5% decrease

PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens.

View company